Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 7—July 2004

Integrons in Salmonella Keurmassar, Senegal

On This Page
Article Metrics
citations of this article
EID Journal Metrics on Scopus

Cite This Article

To the Editor: Infections caused by Salmonella are the primary cause of foodborne diseases; multidrug resistance to Salmonella enterica subsp. enterica is increasing. The selective pressure created by the widespread use of antimicrobial agents in animals and humans as prophylactic and therapeutic agents may have contributed to the dissemination of resistant bacterial strains. In 2000, the new serovar Keurmassar (35:c:1,2) of S. enterica, was described in Senegal (1). Integrons are efficient gene-capture systems by site-specific recombination and are involved in antimicrobial-drug resistance in gram-negative bacteria (2). Three classes of integrons are well characterized and are involved in antimicrobial resistance. Integrons have been found in different nontyphoidal serovars of S. enterica and recently in serovar Typhimurium (3).

We evaluated the contribution of integrons to the antimicrobial drug resistance of eight isolates of S. enterica serovar Keurmassar sent to the Senegalese National Salmonella and Shigella Reference Laboratory at the Pasteur Institute in Dakar from March to May 2000. One strain was isolated from poultry flesh, and seven strains were isolated from human stool or blood samples. Susceptibility testing was performed by disk diffusion method on Mueller-Hinton agar according to the Comité de l’antibiogramme, Société Française de Microbiologie, recommendations. The eight strains expressed an extended-spectrum β-lactamase, which was previously identified as SHV-12 (1). The strains were also resistant to aminoglycosides (amikacin, gentamicin, netilmicin, spectinomycin, streptomycin, and tobramycin), chloramphenicol, sulfamethoxazole, tetracycline, and trimethoprim. Genomic diversity was studied by pulsed-field gel electrophoresis (PFGE) and analysis of XbaI restriction fragments as described previously (3). The eight strains isolated from poultry and humans specimens showed identical PFGE patterns, which suggested that all strains of S. enterica serovar Keurmassar isolated until May 2000 in Senegal belonged to the same clone.

Strains were screened for the integrons by polymerase chain reaction by using three sets of primers specific for the intI1, intI2, and intI3 genes coding for the integrase as described previously (3). The intI1 gene was detected in all strains. Class 2 or 3 integrons were not detected. Cassette assortment in class 1 integrons was determined by using the primers 5′CS and 3′CS complementary to the 5′ and 3′ segments as described previously (3). With these primers, we obtained two amplification products of 1 kb and 1.7 kb for each strain, which suggested that all strains contained at least two class 1 integrons. Sequencing of these amplification products showed that the first product of 1 kb contained the aadA2 cassette, which confers resistance to streptomycin and spectinomycin. The second amplicon of 1.7 kb carried a new arrangement of two cassettes: aac(6′)-IIc, which confers resistance to gentamicin, netilmicin, and tobramycin; and ereA2, which encodes resistance to erythromycin. Class 1 integrons were previously found in strains of S. enterica of different serovars: Agona, Albany, Brandenburg, Enteritidis, Goldcoast, Hadar, Infantis, Ohio, Panama, Poona, Saintpaul, Typhi, Typhimurium, Virchow, and Worthington (37). All these integrons, except that of serovar Infantis, contained a streptomycin-spectinomycin resistance determinant, aadA2 or mostly aadA1, alone or in combination with other gene cassettes. The cassette aac(6′)-IIc was previously described in a single class 1 integron in Pseudomonas aeruginosa (AF162771). The ereA2 cassette was first described in Providencia stuartii (8) in a class 1 integron. This cassette was since described in class 1 integrons of clinical gram-negative isolates and recently in a class 2 integron in Escherichia coli (9). To determine whether the resistance determinants carried by the integrons were transferable, we performed a conjugation experiment from S. enterica serovar Keurmassar to an E. coli strain resistant to nalidixic acid. We first used a selective medium containing nalidixic acid 50 μg/mL plus 25 μg/mL of streptomycin, one of the two integrons carrying the aadA2 cassette. All antimicrobial drug resistances were transferred at once from each strain to E. coli. The analysis of plasmid content prepared by alkaline lysis method from all transconjugants showed a single plasmid of >30 kb. The polymerase chain reaction analysis of the plasmid DNA confirmed the transfer of the two integrons, which suggested that the integrons were borne by a conjugative plasmid.

The multidrug resistance of these strains could be explained by the fact that antimicrobial agents are used extensively in the poultry industry in Senegal to reduce deaths and to increase productivity (1). Moreover, in Senegal, as in many countries in Africa, antimicrobial agents are sold over the counter, which leads to self-medication, thus increasing the selective pressure.

This is the first finding of integrons in the newly described serovar Keurmassar of S. enterica. One integron contained two cassettes, aac(6′)-IIc and ereA2. This was also the first finding of such an integron with a new arrangement of these two cassettes in a clonal strain of S. enterica serovar Keurmassar that had recently emerged. Indeed, the aac(6′)-IIc cassette was described only once in P. aeruginosa. Moreover, aminoglycosides are not used extensively in Africa because they are very expensive. Therefore, determining how this cassette combination was selected is difficult. The strains studied were resistant to multiple antimicrobial agents, including broad-spectrum cephalosporins by production of the extended-spectrum β-lactamase SHV-12. The two class 1 integrons described here could account for the resistance to only a few drugs. The blaSHV-12 gene was not carried by an integron. Otherwise, ampicillin, trimethoprim, and tetracycline are the antimicrobial agents commonly used to treat diarrheal diseases in Africa. All of the strains studied were resistant to these antimicrobials agents. Trimethoprim resistance dfr genes are frequently found in integrons (2). However, in this study, we were not able to detect integrons containing dfr cassettes.

The presence of a conjugative plasmid and integrons in this serovar is of clinical importance. Indeed, the spread of the multiple antimicrobial agent resistance to other Salmonella serovars or gram-negative bacteria might easily occur by the transfer of such a plasmid. Moreover, integrons could allow the acquisition of new genes.

Dr. Gassama-Sow is a microbiologist at the Pasteur Institute in Dakar, Senegal. Her primary research interests include the epidemiology and antimicrobial drug resistance of enteropathogens.


Amy Gassama-Sow*†, Awa Aïdara-Kane†, Nabil Raked*, François Denis*, and Marie-Cecile Ploy*Comments to Author 
Author affiliations: *Laboratoire de Bactériologie-Virologie-Hygiène, Limoges, France; †Institut Pasteur, Dakar, Sénégal



  1. Cardinale  E, Colbachini  P, Perrier-Gros-Claude  JD, Gassama  A, Aïdara-Kane  A. Dual emergence in food and human of a novel multiresistant serotype of Salmonella in Senegal: Salmonella enterica subsp. enterica serotype 35:c:1,2. J Clin Microbiol. 2001;39:23734. DOIPubMedGoogle Scholar
  2. Rowe-Magnus  DA, Mazel  D. The role of integrons in antibiotic resistance gene capture. Int J Med Microbiol. 2002;292:11525. DOIPubMedGoogle Scholar
  3. Ploy  MC, Chainier  D, Tran Thi  NH, Poilane  I, Cruaud  P, Denis  F, Integron-associated antibiotic resistance in Salmonella enterica serovar Typhi from Asia. Antimicrob Agents Chemother. 2003;47:14279. DOIPubMedGoogle Scholar
  4. Di Conza  J, Ayala  JA, Power  P, Mollerach  M, Gutking  G. Novel class 1 integron (InS21) carrying blaCTX-M-2 in Salmonella enterica serovar Infantis. Antimicrob Agents Chemother. 2002;46:225761. DOIPubMedGoogle Scholar
  5. Guerra  B, Soto  S, Cal  S, Mendoza  MC. Antimicrobial resistance and spread of class 1 integrons among Salmonella serotypes. Antimicrob Agents Chemother. 2000;44:21669. DOIPubMedGoogle Scholar
  6. Liebana  E, Clouting  C, Cassar  CA, Randall  LP, Walker  RA, Threlfall  EJ, e al. Comparison of gyrA mutations, cyclohexane resistance, and the presence of class I integrons in Salmonella enterica from farm animals in England and Wales. J Clin Microbiol. 2002;40:14816. DOIPubMedGoogle Scholar
  7. Doublet  B, Lailler  R, Meunier  D, Brisabois  A, Boyd  D, Mulvey  MR, Variant Salmonella genomic island 1 antibiotic resistance gene cluster in Salmonella enterica serovar Albany. Emerg Infect Dis. 2003;9:58591.PubMedGoogle Scholar
  8. Plante  I, Centron  D, Roy  PH. An integron cassette encoding erythromycin esterase, ere(A), from Providencia stuartii. J Antimicrob Chemother. 2003;51:78790. DOIPubMedGoogle Scholar
  9. Biskri  L, Mazel  D. Erythromycin esterase gene (ereA) is located in a functional gene cassette in an unusual class 2 integron. Antimicrob Agents Chemother. 2003;47:332631. DOIPubMedGoogle Scholar


Cite This Article

DOI: 10.3201/eid1007.030666

Related Links


Table of Contents – Volume 10, Number 7—July 2004

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Marie-Cécile Ploy, Laboratoire de Bactériologie-Virologie-Hygiène CHU Dupuytren, 2, avenue Martin Luther King, 87042 Limoges Cedex; fax: 33-5 55-05-67-22

Send To

10000 character(s) remaining.


Page created: January 27, 2011
Page updated: January 27, 2011
Page reviewed: January 27, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.